Key result
Nonpeptide angiotensin II receptor antagonists represent a new generation of antihypertensive therapy.
This perspective reviews the development of nonpeptide angiotensin II receptor antagonists as a new class of antihypertensive therapy.
No takes yet. Share an insight, caveat, or question.
May broaden antihypertensive options; leaves open head-to-head outcome trials versus established agents.
Wexler et al. (1996) conducted a review in Hypertension. Nonpeptide Angiotensin II Receptor Antagonists was evaluated. Nonpeptide angiotensin II receptor antagonists represent a new generation of antihypertensive therapy.